Renal Tumors
8
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
A Multicenter Study of RUS NE
Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors
Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & Outcomes
Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging
Study of Cryotherapy for Renal Tumors